| 查看: 497 | 回复: 3 | |||
| 当前主题已经存档。 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
[交流]
【求助】一药物状况
|
|||
| 请教一药物Panomifene的情况，是否已经上市了？？？？ |
回复此楼» 猜你喜欢
文献分享 | 关于T细胞的相关研究
已经有5人回复
-
文献分享 | Nature综述：中山大学团队阐述靶向肿瘤活性氧（ROS）的原理与策略
已经有5人回复
-
药理学论文润色/翻译怎么收费?
已经有109人回复
-
有偿求肠毒素的脆弱拟杆菌（ETBF）
已经有0人回复
-
生防菌的盆栽防效实验
已经有1人回复
-
请教大佬扩散问题
已经有5人回复
-
中文投稿“肿瘤免疫”相关
已经有6人回复
-
2025年药学专业求调剂
已经有1人回复
★
karl2100(金币+1,VIP+0):3Q 5-6 22:08
karl2100(金币+1,VIP+0):3Q 5-6 22:08
|
DR panomifene SUMMARY OVERVIEW DRUG NAME BREAKING NEWS LICENSING SUMMARY No data for any portlets within this tab SUMMARY Drug name panomifene Company EGIS Gyogyszergyar RT (Servier) Highest dev status Discontinued Therapy areas Cancer Actions Anticancer; Estrogen receptor antagonist Target Estrogen receptor Update date 05-MAR-2002 Reason for update indexing updated Top OVERVIEW Egis has discontinued development of panomifene, an estrogen antagonist which had reached phase I clinical trials as a potential treatment for cancer [231757]. Top DRUG NAME Names associated with this drug Name Type panomifene USAN, INN 77599-17-8 CAS RN EGIS-5650 Research Code panomifine Top BREAKING NEWS No news items found. Disclaimer | Terms of Use | Privacy Policy | Copyright © 2009 THOMSON REUTERS [ Last edited by acdmail1 on 2009-5-6 at 13:04 ] |
3楼2009-05-06 13:02:13